Skip to Content

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in News for Health Professionals

Radiographic Knee Osteoarthritis Tied to Increased Risk for Death

Radiographic knee osteoarthritis (RKOA) is associated with an increased risk for mortality from cardiovascular disease (CVD), diabetes, and renal diseases, but self-reported OA is not, according to a study published in the December issue of the International Journal of Epidemiology. Angelico Mendy, M.D., from the University of Iowa in Iowa City, and...

Posted today in Medical

Ditch Your Leisure To-Do List

If the fun is often missing from your social activities or play feels like work, researchers at Washington University in St. Louis have an explanation: You're probably overplanning. With so many demands on your time, precise scheduling might be the only way to accomplish everything you want. But while that can help at work and with family responsibilities,...

Posted today in Medical

Disrupted Sleep Plagues Hospital Patients, But New Program Might Help

Anyone who has cared for a hospitalized loved one knows that frequent nighttime sleep interruptions -- caused by noise or nursing checks -- are a big concern. But in a new study, a Chicago hospital adopted sleep-friendly measures for patients that led to fewer nighttime awakenings without compromising care. Nighttime room entries dropped by 44 percent...

Posted today in New Drug Approvals

FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin

FDA today approved Ontruzant (trastuzumab-dttb), a biosimilar to U.S.-licensed Herceptin (trastuzumab). A biosimilar product is a biological product that is approved based on a showing that it is highly similar to an already-FDA approved biological product, known as a reference product. The biosimilar also must be shown to have no clinically meaningful...

Posted yesterday in FDA Alerts

FDA Updates on Angiotensin II Receptor Blocker (ARB) Recalls

Investigation ongoing – This page to be updated as more information is available IMPORTANT: Medications containing only amlodipine or hydrochlorothiazide (HCTZ) are not being recalled. Manufacturers are recalling medications containing amlodipine in combination with valsartan or losartan, and medications containing hydrochlorothiazide HCTZ in combination...

Posted today in Medical

Health Highlights: Jan. 18, 2019

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Gluten-Free Chicken Nuggets Recalled by Perdue Foods Possible wood contamination has led to the recall of more than 68,000 pounds of gluten-free chicken nuggets from Perdue Foods, the U.S. Department of Agriculture's Food Safety and Inspection Service...

Posted today in Medical

Study Examines Link Between Type 1 Diabetes, Broken Bones

Poor blood sugar control puts people with type 1 diabetes at increased risk for fragility fractures, a new study shows. A fragility fracture is a broken bone caused by a fall from standing height or less. For the study, researchers analyzed data on more than 3,300 people with type 1 diabetes and more than 44,000 with type 2 diabetes, in the United...

Posted today in Medical

AHA: Taking Medicine for a Cold? Be Mindful of Your Heart

Flu has so far infected more than 6 million Americans this season, and winter colds are making their rounds. If you've been hit by either, you may be thinking about heading to your local pharmacy to relieve your aches, pains and congestion. But before you do, you need to consider how some over-the-counter cold medicines may impact your heart. "People...

Posted today in Medical

Frailty a Risk Factor for Dementia

Frailty is associated with a higher risk of both Alzheimer's disease and its crippling symptoms, a new study shows. "By reducing an individual's physiological reserve, frailty could trigger the clinical expression of dementia when it might remain asymptomatic in someone who is not frail," said study leader Dr. Kenneth Rockwood, a professor at Dalhousie...

Posted today in Medical

Many Oncologists in the Dark About LGBTQ Health Needs

Most cancer specialists are comfortable treating LGBTQ patients, but many aren't confident in their knowledge about these patients' specific health needs, a new survey finds. "Cancer care within the LGBTQ community is a largely ignored public health issue," said Gwendolyn Quinn, a professor in the Departments of Obstetrics and Gynecology and Population...

Read more news...

Recently added consumer and prescribing information: Ultomiris, Motegrity, Xospata, Daurismo, Vitrakvi, Lorbrena, Yupelri, Bijuva, Xofluza, Talzenna

Posted in Blog

No Easy Fix To The Opioid Crisis

Despite numerous law changes and restrictions on prescribing, the number of people dying from opioid-related drug overdoses continues to increase. Today, and every day after this one, 130 Americans on average will die from taking an opioid. But can anything more be done about reversing these shocking statistics? Yes, it could, but will it? Current […]

Posted in Blog

A Baby Boomer’s Least Desirable Trait: HCV

If you were born between 1946 and 1964, then you are in good company. Steven Spielberg, Bill Gates, and Oprah Winfrey are just some of the iconic figures that make up this influential generation, not to mention the numerous notable actors, politicians, and sports stars. But baby boomers are also notorious for another, not so […]

Posted in Blog

Great Expectations: Medical and Drug Innovations for 2019

If 2018 was touted as the year for blockbuster drugs, then you had better hang onto your seat for 2019. This year promises some innovations that will transform healthcare. Look forward to treatments that may finally offer an effective alternative to opioids, protocols that give the green light for an expanded window to treat stroke, […]

See more blog posts or follow us on twitter.